Benzenepropanamide, a-(dimethylamino)-N-[3-(1-methylethyl)-7-(1-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI) (24532-77-2)

Identification
Name:	Benzenepropanamide, a-(dimethylamino)-N-[3-(1-methylethyl)-7-(1-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Synonyms:	MyrianthineB (8CI); 2-Oxa-6,9-diazabicyclo[10.2.2]hexadecane, benzenepropanamide deriv.;Alkaloid AM 1, from Antidesma montana
CAS:	24532-77-2
Molecular Formula:	C31H42 N4 O4
Molecular Structure:
Properties
Safety Data

Other Product

Benzenepropanamide, a-(dimethylamino)-N-[7-(1-hydroxy-2-methylpropyl)-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Benzenepropanamide,R-(dimethylamino)-N- [(3R,4S,7S)-3-(1-methylethyl)-7-[(1R)-1- methylpropyl]-5,8-dioxo-2-oxa-6,9- diazabicyclo[10.2.2]hexadeca-10,12,14,15- tetraen-4-yl]-,(RS)-
Benzenepropanamide, a-(dimethylamino)-N-[(3R,4S,7S)-3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-,(aR)-
Benzenepropanamide, a-(methylamino)-N-[3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
1H-Indole-3-propanamide,a-(dimethylamino)-N-[3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Benzenepropanamide,R-(dimethylamino)-N- [(3R,4S,7R)-7-[(S)-hydroxyphenylmethyl]-3- (1-methylethyl)-5,8-dioxo-2-oxa-6,9- diazabicyclo[10.2.2]hexadeca-10,12,14,15- tetraen-4-yl]-,(RS)-
Benzenepropanamide,R-(dimethylamino)-N- [(3S,4S,7R,10Z)-7-[(S)-hydroxyphenylmethyl]- 3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9- diazabicyclo[10.2.2]hexadeca-10,12,14,15- tetraen-4-yl]-,(RS)-
Benzenepropanamide, a-(methylamino)-N-[7-(1-methylpropyl)-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Benzenepropanamide, a-(dimethylamino)-N-[11-methoxy-3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14,15-trien-4-yl]-(9CI)
Nalpha,Nalpha-dimethyl-N-[(10Z)-3-(1-methylethyl)-7-(1-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]tryptophanamide
Pentanamide,2-(dimethylamino)-3-methyl-N- [7-(1-methylethyl)-5,8-dioxo-3-phenyl-2- oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,- 15-tetraen-4-yl]-
Pentanamide,2-(dimethylamino)-3-methyl-N- [3-(1-methylethyl)-7-(1-methylpropyl)-5,8- dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca- 10,12,14,15-tetraen-4-yl]-
Butanamide,2-(dimethylamino)-3-methyl-N-[3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-
Pentanamide,2-(dimethylamino)-4-methyl-N- [(3R,4S,7S)-3-(1-methylethyl)-7-(2-methylpropyl)- 5,8-dioxo-2-oxa-6,9-diazabicyclo- [10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-,(2S)-
(αS)-N-[(3R,4R,7R)-7-[(S)-(Acetyloxy)phenylmethyl]-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetren-4-yl]-α-(dimethylamino)benzenepropanamide
Pentanamide,2-(dimethylamino)-4-methyl-N-[7-(1-methylpropyl)-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
2-Propenamide,N-[3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-3-phenyl-(9CI)
Benzenepropanamide,R-(dimethylamino)-N- [11-hydroxy-3-(1-methylethyl)-7-(1-methylpropyl)- 5,8-dioxo-2-oxa-6,9-diazabicyclo- [10.2.2]hexadeca-12,14,15-trien-4-yl]-
Butanamide,2-(dimethylamino)-N-[7-[(4-hydroxyphenyl)methyl]-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-3-methyl-(9CI)
Benzenepropanamide, a-(dimethylamino)-N-[(3S,4S,7S,11R)-11-hydroxy-3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14,15-trien-4-yl]-,(aS)-